Berberine in the treatment of polycystic ovary syndrome

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is a hormonal disorder most common in women in reproductive age. The global incidence varies from 6% to 20% depending on the diagnostic criteria used, and is also the most common cause of infertility. This disease is related to insulin resistance and hyperinsulinemia. Berberine is a compound that affects the cardiovascular system and carbohydrate metabolism, which is why there are attempts to introduce it into the therapy of patients with PCOS. 
Material and methods: The literature was reviewed in the PubMed scientific base in the years 2012-2022 using the following keywords: berberine, polycystic ovary syndrome. 
Results: Research show that the use of berberine may have a positive effect on the waist circumference and waist-to-hip ratio, improve lipid parameters, lower the concentration of androgens, and reduce insulin resistance. In addition, a promising effect is the stabilization of the menstrual cycle and improvement of ovulation. There are reports that this drug may also restore the normal composition of the intestinal microflora disrupted in PCOS. Side effects are rare and mild, which confirms the safety of this substance. 
Conclusions: Polycystic ovary syndrome affects many women, leading to numerous and serious side effects, so it is important to develop an effective treatment with as few side effects as possible. Berberine is a promising prospect, but more studies are needed on larger groups of patients to confirm these reports and develop an effective treatment regimen. 
Keywords: berberine, polycystic ovary syndrome.